|
US3342824A
(en)
*
|
1964-12-07 |
1967-09-19 |
Lilly Co Eli |
Normorphines
|
|
GB1123768A
(en)
*
|
1966-07-29 |
1968-08-14 |
Smith Kline French Lab |
New thebaine and oripavine derivatives and processes for preparing the same
|
|
US3466277A
(en)
*
|
1966-12-13 |
1969-09-09 |
Boehringer Sohn Ingelheim |
N-allylic cyclohexyl lower alkyl normorphines
|
|
US3905981A
(en)
*
|
1973-10-12 |
1975-09-16 |
Research Corp |
N-dealkylation of tertiary amines
|
|
NO802139L
(no)
*
|
1979-08-09 |
1981-02-10 |
Mallinckrodt Inc |
Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
|
|
US4613668A
(en)
*
|
1983-12-22 |
1986-09-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
|
|
US4722928A
(en)
*
|
1985-12-02 |
1988-02-02 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
|
|
US4990617A
(en)
*
|
1985-12-02 |
1991-02-05 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans and derivatives
|
|
US5668285A
(en)
*
|
1986-10-31 |
1997-09-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
|
|
AU642447B2
(en)
*
|
1989-10-16 |
1993-10-21 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via N-nor intermediates
|
|
US5028612A
(en)
*
|
1990-03-22 |
1991-07-02 |
Hillel Glover |
Method for treating emotional numbness
|
|
EP1782834A3
(en)
*
|
2003-03-13 |
2007-08-01 |
Controlled Chemicals, Inc. |
Oxycodone conjugates with lower abuse potential and extended duration of action
|
|
DE602004024963D1
(de)
*
|
2003-03-13 |
2010-02-25 |
Controlled Chemicals Inc |
Oxycodon- konjugate mit niedrigerem missbrauch- potential und ausgedehnter tätigkeitsdauer
|
|
ES2357216T3
(es)
*
|
2005-06-16 |
2011-04-20 |
Mallinckrodt, Inc. |
Una ruta de síntesis de 14-hidroxil-opiáceos a través de 1-halo-tebaína o análogos.
|
|
JP2010510328A
(ja)
*
|
2006-11-22 |
2010-04-02 |
プロジェニックス ファーマスーティカルス インコーポレーテッド |
７，８−飽和−４，５−エポキシ−モルフィナニウム類似体の（ｒ）−ｎ−立体異性体
|
|
CA2681740A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Mallinckrodt Inc. |
Improved preparation of oxymorphone from oripavine
|
|
WO2008127188A1
(en)
|
2007-04-12 |
2008-10-23 |
Allbay Ab |
N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
|
|
ES2423180T3
(es)
*
|
2007-04-16 |
2013-09-18 |
Mallinckrodt Llc |
Nueva reducción de opiáceos mediante reacción de transferencia de hidrógeno catalítica
|
|
NZ586203A
(en)
*
|
2007-12-17 |
2012-10-26 |
Mallinckrodt Llc |
Process and compounds for the production of (+) opiates
|
|
CN101896487A
(zh)
*
|
2007-12-17 |
2010-11-24 |
马林克罗特公司 |
N-甲基吗啡喃的n-脱甲基化
|
|
ES2566559T3
(es)
*
|
2008-09-30 |
2016-04-13 |
Mallinckrodt Llc |
Procesos para la alquilación de grupos amino secundarios de derivados de morfinano
|
|
WO2011008636A1
(en)
*
|
2009-07-15 |
2011-01-20 |
Mallinckrodt Inc. |
3-oxy-hydromorphone derivatives
|